Your provider should assess these factors alongside medication efficacy data and potential contraindications specific to your health status
Because Truveta Data provides the most complete, timely, and clean de-identified EHR data, including full patient medical records, notes, and images, linked with claims, SDOH, and mortality data for more than 100 million patients across the US, we can show the latest trends in these medications, including the early uptake in tirzepatide labeled for obesity (Zepbound), which was approved by the FDA in November 2023
*This is intended to provide general information, not legal advice
As the target dose changes every 4 weeks in the escalation protocol, researchers may reconstitute at different concentrations or adjust syringe draw volumes the calculator handles both approaches with visual syringe guidance